This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Hybrigenics S.a., Laboratoire Theramex. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: The Innovations of Gilles Pellegrino
Introduction
Gilles Pellegrino is a notable inventor based in Menton, France. He has made significant contributions to the field of chemistry, particularly in the development of processes related to bicyclic structures and steroid compounds. With a total of two patents to his name, Pellegrino's work showcases his expertise and innovative spirit.
Latest Patents
Pellegrino's latest patents include a process for isomerizing fused bicyclic structures and the preparation of vitamin D analogs. This invention focuses on isomerizing trans fused bicyclic derivatives into cis fused bicyclic derivatives, which is crucial for the synthesis of vitamin D and its analogs. Another significant patent involves a process for introducing a double bond into position 15, 16 of a steroid. This invention details the preparation of a compound that serves as an intermediate in the production of gestodene, a synthetic progestin.
Career Highlights
Throughout his career, Gilles Pellegrino has worked with various companies, including Hybrigenics S.A. and Laboratoire Theramex. His experience in these organizations has allowed him to refine his skills and contribute to important advancements in pharmaceutical chemistry.
Collaborations
Pellegrino has collaborated with notable colleagues such as Jean-Luc Moutou and Florent Mouton. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in his field.
Conclusion
Gilles Pellegrino's contributions to the field of chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important compounds and processes in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
